AFL · NYSE · Insurance - Life

Aflac (AFL)

Pays cash benefits through supplemental health and life insurance in Japan and the United States.

$114.42
vs last close−0.76 (−0.66%)
Loading prices…

Aflac IncorporatedAFL
Financial sector

Sells supplemental health and life insurance in Japan and the U.S., earning premiums and investment income while paying cash benefits for covered events. Cancer and medical policies anchor the Japan segment, the principal earnings contributor, while the U.S. business reaches individuals and employers mainly through workplaces.

Pays cash benefits that help cover medical and nonmedical costs left by primary insurance, through two segments: Aflac Japan and Aflac U.S. Japan centers on cancer and medical coverage, supplemented by nursing-care and life products; the U.S. sells accident, disability, critical-illness, hospital-indemnity, dental, vision, and life policies.

Pairs product specialization with broad distribution. Japanese policies reach customers through independent and affiliated agencies, including Japan Post, Dai-ichi Life, Daido Life, and banks. U.S. policies are sold mainly at workplaces through independent agents and brokers, alongside a direct-to-consumer channel.

Premiums and investment income fund policyholder benefits. Japan is the principal earnings contributor, making results sensitive to Japanese insurance regulation, partner distribution, interest rates, and yen-dollar translation.

Company facts

CEODaniel P. Amos
ListedMar 17, 1980
ExchangeNYSE
HeadquartersColumbus, GA
CountryUnited States
Employees12,716
CIK0000004977
ISINUS0010551028

Market cap$58.62B
EPS (ttm)$9.28
P/E (ttm)12.41
ROE16.4%
P/B1.93
P/S3.24
Dividend yieldDiv yield2.09%
Beta−0.17vs XLF 0.78

Price target$122.00+5.9%Average of 32 analysts
ConsensusHold18 of 32 analysts
Ratings

Target rangeAs of Sep 21, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Aug 19, 2026Wells FargoReiterate
Rating: Target: $105
Rating: Equal WeightTarget: $122
Aug 19, 2026Wolfe ResearchInitiate
Rating:
Rating: Underperform
Aug 10, 2026Piper SandlerReiterate
Rating: Target: $130
Rating: OverweightTarget: $138
Aug 10, 2026Mizuho SecuritiesTarget
Target: $112
Target: $116
Jul 10, 2026JefferiesReiterate
Rating: Target: $84
Rating: HoldTarget: $108

Next report
Nov 4, 26
in 43 days
EPS estimate
$1.81
Revenue estimate
$4.10B
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Feb '25Apr '25Aug '25Nov '25Feb '26Apr '26Aug '26Nov '26
Reported$1.56$1.66$1.78$2.49$1.57$1.75$1.75Pending
Estimate$1.62$1.67$1.70$1.77$1.69$1.79$1.76$1.81
Surprise−3.7%−0.6%+4.7%+40.7%−7.1%−2.2%−0.6%

RevenueReportedEstimate

Feb '25Apr '25Aug '25Nov '25Feb '26Apr '26Aug '26Nov '26
Reported$5.50B$3.45B$4.22B$4.79B$4.87B$4.35B$4.12BPending
Estimate$4.33B$4.28B$4.33B$4.37B$4.25B$4.20B$4.14B$4.10B
Surprise+27.0%−19.3%−2.6%+9.8%+14.5%+3.4%−0.6%
Estimate$1.81
ReportedDue Nov 4, 2026
Estimate$4.10B
ReportedDue Nov 4, 2026
View details

Debt to equity28.80%
Current ratio1,130.50%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$3.04B$5.50B$3.45B$4.22B$4.79B$4.90B$4.32B$4.08B
Net income−$93.0M$1.90B$29.0M$599.0M$1.64B$1.38B$1.02B$825.0M
Net margin0.0%34.6%0.8%14.2%34.2%28.2%23.6%20.2%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income$92.0M$2.14B$145.0M$822.0M$1.99B$1.60B$1.23B$995.0M
YoY growth−94.9%+636.2%−93.3%−59.3%+2,067.4%−25.0%+744.8%+21.0%

Balance sheet, Jun 30, 2026Cash & short-term investments $93.65B · Total debt $8.73B · Total assets $115.96B · Shareholders' equity $30.31B

Revenue
$4.08B
Operating income
$995.0M
Net income
$825.0M
View details

Dividend yield
2.09%
Next ex-date
Nov 19, 26
estimated · in 58 days
Annual dividend
$2.41
per share
Schedule
Quarterly
4 payments a year

HistoryDividendAnnual yield

Nov '24Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26
Dividend$0.50$0.58$0.58$0.58$0.58$0.61$0.61$0.61
Annual yield1.81%1.99%2.09%2.08%2.12%2.07%2.03%2.07%
Ex-dateNov 20Feb 19May 21Aug 20Nov 19Feb 18May 20Aug 19
Payment dateDec 2Mar 3Jun 2Sep 2Dec 1Mar 2Jun 1Sep 1
View details

Institutions69.25%347.19M shares
1,756 holders · as of Jun 30, 2026
Insiders0.32%1.61M shares
20 holders · as of Sep 18, 2026
Strategic holders8.34%41.79M shares
1 holder · as of Jan 11, 2017
Other22.09%110.76M shares
remainder

501.34M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
Japan Post Holdings Co., Ltd.Institution
10.15%50.90Mas of Jun 30, 2026
Norges Bank (The Central Bank of Norway)Strategic
8.34%41.79Mfiled Jan 11, 2017
BlackRock, Inc.Institution
6.96%34.92Mas of Jun 30, 2026
Vanguard Capital Management LLCInstitution
5.96%29.90Mas of Jun 30, 2026
Vanguard Portfolio Management LLCInstitution
4.86%24.36Mas of Jun 30, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Sep 17, 2026Japan Post Holdings Co., Ltd.10 percent owner−12,900$116.58
Sep 16, 2026Masatoshi Koideofficer: Pres. and Rep. Director, ALIJ−13,201$118.01
Sep 16, 2026Japan Post Holdings Co., Ltd.10 percent owner−13,800$117.49
Sep 15, 2026Japan Post Holdings Co., Ltd.10 percent owner−13,600$117.34
Sep 14, 2026Japan Post Holdings Co., Ltd.10 percent owner−13,600$116.74
View details

  • Unum Group

    Top U.S. rival in group disability and worksite voluntary benefits.

  • MetLife

    Global benefits giant bundling supplemental health into core employer plans.

  • Globe Life

    U.S. supplemental cancer and life specialist for middle-income households.

  • Prudential Financial

    Group insurance and Gibraltar Life Japan contest both Aflac markets.

Compare

CompanyPriceChange
Aflac$114.42−0.66%$58.62B12.415.63.2−2.4%
Unum Group$93.12−0.47%$14.81B21.810.41.1−13.8%
MetLife$95.33−1.36%$62.18B18.59.00.8+10.0%
Globe Life$169.78−1.39%$13.37B11.410.22.2+8.0%
Prudential Financial$116.61−1.62%$41.13B10.78.30.6+2.8%
Median15.09.61.0+5.4%